Additional file 3: of MiR-362-5p promotes the malignancy of chronic myelocytic leukaemia via down-regulation of GADD45α

MiR-362-5p expression altered the proliferation of CML cells in dose-dependent manner. (A) Relative cell growth rate of BV173 and K562 cells after transfected with miR-362-5p mimics for 48 h in different concentration. (B) Relative cell survival rate of BV173 and K562 cells after transfected with miR-362-5p inhibitor for 48 h in different concentration. Data in histograms are represented as mean ± SD. T test, *P < 0.05. **P < 0.01 compared with the control. mc: miR-362-5p mimic control; 10 m, 25 m, 50 m, 100 m:10, 25, 50, 100 mM miR-362-5p mimic; ic: miR-362-5p inhibitor control; 10i, 25i, 50i, 100i:10, 25, 50, 100 mM miR-362-5p inhibitor. (DOC 71 kb